tm logo
TRANSCON
Live/Registered
REGISTERED

on 15 Oct 2019

Last Applicant/ Owned by

DK-2900 Hellerup

DK

Serial Number

79221044 filed on 17th Jul 2017

Registration Number

5881763 registered on 15th Oct 2019

in the Principal Register

Correspondent Address

Paul F Kilmer

Paul F Kilmer HOLLAND & KNIGHT LLP

Suite 1100

Washington, DC 20006

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

TRANSCON

Scientific research within the medical, pharmaceutical and bacteriological area and consultancy and information relating thereto; conducting of tests regarding medical applications in the nature of providing medical testing services in the field of sustained release of pharmaceutical and veterinary drugs; designing and development of medical equipment; designing pharmaceutical and medical preparat Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Licensing of industrial property rights; legal services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific research within the medical, pharmaceutical and bacteriological area and consultancy and information relating thereto; conducting of tests regarding medical applications in the nature of providing medical testing services in the field of sustained release of pharmaceutical and veterinary drugs; designing and development of medical equipment; designing pharmaceutical and medical preparations in the nature of pharmaceutical drug development services; development of pharmaceutical formulations; design and development of pharmaceutical granulation technology and pharmaceutical tablet technology and consultancy and information relating thereto


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary preparations, namely, a drug delivery system in the form of polymer based prodrug formulations which allow for the controlled or continuous release of a wide variety of therapeutic agents for the treatment of mental illness and physical illness in the nature of disorder of the endocrine system, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious disease, enzyme replacement therapy, anti-inflammatory disease, pain, respiratory system disorder, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wound healing; sanitary preparations for medical purposes; dietetic substances adapted for medical use; disinfectants; fungicides; herbicides


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79221044

Mark Type

No Service Mark

Attorney Docket Number

No 115191.00010

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Oct 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10th Mar 2024NEW REPRESENTATIVE AT IB RECEIVED
24th Dec 2021NEW REPRESENTATIVE AT IB RECEIVED
28th Oct 2021NEW REPRESENTATIVE AT IB RECEIVED
21st Feb 2020FINAL DECISION TRANSACTION PROCESSED BY IB
04th Feb 2020FINAL DISPOSITION NOTICE SENT TO IB
03rd Feb 2020FINAL DISPOSITION PROCESSED
15th Jan 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15th Oct 2019REGISTERED-PRINCIPAL REGISTER
23rd Aug 2019NOTIFICATION PROCESSED BY IB